Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0552
D

Failure to Inform Residents of Risks and Benefits of Psychotropic Medications

Camilla, Georgia Survey Completed on 05-16-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that residents were fully informed and understood the risks and benefits of psychotropic medication use prior to administration. According to the facility's policy, residents have the right to participate in decision-making regarding their care, which includes being informed about their health status, care, and treatments. However, for two residents reviewed, there was no evidence that the risks and benefits of psychoactive medications were explained to them or their representatives before the medications were administered. One resident, who was cognitively intact and admitted with diagnoses including major depressive disorder, anxiety, and dementia, received multiple psychotropic medications such as antipsychotics and antidepressants. The consent form on file was signed by a representative prior to admission and did not specify the risks and benefits of the medications. During an interview, the resident confirmed that no one had explained the risks and benefits of her medications to her, and she expected the facility's doctor to do so. Another resident, who was severely cognitively impaired and admitted with diagnoses of dementia and depression, also received several psychotropic medications. The consent form for this resident was similarly signed by a representative before admission and lacked information about the risks and benefits of the medications. Facility staff, including the Infection Preventionist and the DON, acknowledged during interviews that the consent forms did not include this information and that it was their expectation that such education should have been provided prior to medication administration.

An unhandled error has occurred. Reload 🗙